Last data update: May 20, 2024. (Total: 46824 publications since 2009)
Records 1-3 (of 3 Records) |
Query Trace: Rapposelli K[original query] |
---|
Testing for hepatitis C virus infection among adults aged 18 in the United States, 2013-2017
King H , Soh JE , Thompson WW , Brown JR , Rapposelli K , Vellozzi C . Public Health Rep 2021 137 (6) 1107-1117 OBJECTIVE: Approximately 2.4 million people in the United States are living with hepatitis C virus (HCV) infection. The objective of our study was to describe demographic and socioeconomic characteristics, liver disease-related risk factors, and modifiable health behaviors associated with self-reported testing for HCV infection among adults. METHODS: Using data on adult respondents aged ≥18 from the 2013-2017 National Health Interview Survey, we summarized descriptive data on sociodemographic characteristics and liver disease-related risk factors and stratified data by educational attainment. We used weighted logistic regression to examine predictors of HCV testing. RESULTS: During the study period, 11.7% (95% CI, 11.5%-12.0%) of adults reported ever being tested for HCV infection. Testing was higher in 2017 than in 2013 (adjusted odds ratio [aOR] = 1.27; 95% CI, 1.18-1.36). Adults with ≥some college were significantly more likely to report being tested (aOR = 1.60; 95% CI, 1.52-1.69) than adults with ≤high school education. Among adults with ≤high school education (but not adults with ≥some college), those who did not have health insurance were less likely than those with private health insurance (aOR = 0.78; 95% CI, 0.68-0.89) to get tested, and non-US-born adults were less likely than US-born adults to get tested (aOR = 0.77; 95% CI, 0.68-0.87). CONCLUSIONS: Rates of self-reported HCV testing increased from 2013 to 2017, but testing rates remained low. Demographic characteristics, health behaviors, and liver disease-related risk factors may affect HCV testing rates among adults. HCV testing must increase to achieve hepatitis C elimination targets. |
Global health security: Protecting the United States in an interconnected world
Bunnell RE , Ahmed Z , Ramsden M , Rapposelli K , Walter-Garcia M , Sharmin E , Knight N . Public Health Rep 2019 134 (1) 3-10 On September 30, 2014, the Centers for Disease Control and Prevention (CDC) received a report of a laboratory-confirmed case of Ebola virus disease (Ebola) in a man who had traveled from Liberia to Dallas, Texas. Two nurses who cared for him were eventually confirmed as having Ebola. Three weeks later, a physician who had recently returned from West Africa to New York City developed symptoms and had laboratory confirmation of Ebola infection. These 4 cases placed an astounding burden of work on the state and local health departments involved and required the efforts of hundreds of health care workers.1–3 The economic impact was steep; Congress allocated more than $570 million to CDC for the US domestic Ebola response as part of a larger $5.4 billion appropriation for Ebola and health security.4 The 4 cases of Ebola illustrate how the interconnectedness of today’s world brings an increased risk for disease acquisition, both in the United States and abroad. |
Personally identifiable information in state laws: Use, release, and collaboration at health departments
Begley EB , Ware JM , Hexem SA , Rapposelli K , Thompson K , Penn MS , Aquino GA . Am J Public Health 2017 107 (8) e1-e5 Despite benefits to sharing data among public health programs, confidentiality laws are often presumed to obstruct collaboration or data sharing. We present an overview of the use and release of confidential, personally identifiable information as consistent with public health interests and identify opportunities to align data-sharing procedures with use and release provisions in state laws to improve program outcomes. In August 2013, Centers for Disease Control and Prevention staff and legal researchers from the National Nurse-Led Care Consortium conducted a review of state laws regulating state and local health departments in 50 states and the District of Columbia. Nearly all states and the District of Columbia employ provisions for the general use and release of personally identifiable information without patient consent; disease-specific use or release provisions vary by state. Absence of law regarding use and release provisions was noted. Health departments should assess existing state laws to determine whether the use or release of personally identifiable information is permitted. Absence of direction should not prevent data sharing but prompt an analysis of existing provisions in confidentiality laws. (Am J Public Health. Published online ahead of print June 22, 2017: e1-e5. doi:10.2105/AJPH.2017.303862). |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 20, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure